Poly Medicure [POLYMED] vs Prevest Denpro [PREVEST] Detailed Stock Comparison
Poly Medicure
NSE
Loading...
Prevest Denpro
BSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Poly Medicure wins in 5 metrics, Prevest Denpro wins in 15 metrics, with 0 ties. Prevest Denpro appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Poly Medicure | Prevest Denpro | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 53.26 | 34.49 | Prevest Denpro |
| Price-to-Book Ratio | 7.04 | 6.22 | Prevest Denpro |
| Debt-to-Equity Ratio | 6.52 | 0.00 | Prevest Denpro |
| PEG Ratio | 2.77 | 1.73 | Prevest Denpro |
| EV/EBITDA | 40.95 | 25.67 | Prevest Denpro |
| Profit Margin (TTM) | 21.18% | 28.86% | Prevest Denpro |
| Operating Margin (TTM) | 20.56% | 30.58% | Prevest Denpro |
| EBITDA Margin (TTM) | 20.56% | 30.58% | Prevest Denpro |
| Return on Equity | 12.24% | 17.20% | Prevest Denpro |
| Return on Assets (TTM) | 10.60% | 16.13% | Prevest Denpro |
| Free Cash Flow (TTM) | $-906.06M | $128.49M | Prevest Denpro |
| Dividend Yield | 0.33% | 0.17% | Poly Medicure |
| 1-Year Return | -18.60% | -8.64% | Prevest Denpro |
| Price-to-Sales Ratio (TTM) | 11.36 | 10.03 | Prevest Denpro |
| Enterprise Value | $187.33B | $5.91B | Poly Medicure |
| EV/Revenue Ratio | 11.10 | 9.03 | Prevest Denpro |
| Gross Profit Margin (TTM) | 68.45% | 77.43% | Prevest Denpro |
| Revenue per Share (TTM) | $168 | $55 | Poly Medicure |
| Earnings per Share (Diluted) | $35.51 | $15.86 | Poly Medicure |
| Beta (Stock Volatility) | 0.01 | 0.43 | Poly Medicure |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Poly Medicure vs Prevest Denpro Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Poly Medicure | -2.06% | -2.49% | -7.56% | -14.74% | -15.41% | -28.70% |
| Prevest Denpro | -0.47% | -1.01% | -6.44% | -2.72% | 7.46% | -9.26% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Poly Medicure | -18.60% | 89.07% | 301.81% | 867.74% | 5,763.15% | 5,763.15% |
| Prevest Denpro | -8.64% | 33.44% | 105.45% | 105.45% | 105.45% | 105.45% |
News Based Sentiment: Poly Medicure vs Prevest Denpro
Poly Medicure
News based Sentiment: MIXED
September was a highly active month for Poly Medicure, driven by significant acquisitions and positive Q1 results. However, a quarter-on-quarter revenue decline and mixed analyst recommendations create a more nuanced investment picture, making it a month of both opportunity and caution.
Prevest Denpro
News based Sentiment: MIXED
September presented a mixed bag for Prevest Denpro, with short-term price increases offset by broader sector declines and persistent valuation concerns. While the company's financial stability is a positive, the negative analyst assessment and fluctuating investor participation create uncertainty, making it a moderately significant month for investors.
Performance & Financial Health Analysis: Poly Medicure vs Prevest Denpro
| Metric | POLYMED | PREVEST |
|---|---|---|
| Market Information | ||
| Market Cap | ₹193.74B | ₹6.65B |
| Market Cap Category | Mid cap | Small cap |
| 10 Day Avg. Volume | 146,443 | 2,840 |
| 90 Day Avg. Volume | 180,925 | 8,133 |
| Last Close | ₹1,910.80 | ₹544.45 |
| 52 Week Range | ₹1,821.20 - ₹3,357.80 | ₹393.60 - ₹686.00 |
| % from 52W High | -43.09% | -20.63% |
| All-Time High | ₹3,357.80 (Oct 28, 2024) | ₹686.00 (Jan 13, 2025) |
| % from All-Time High | -43.09% | -20.63% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.18% |
| Quarterly Earnings Growth | 0.26% | 0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.29% |
| Operating Margin (TTM) | 0.21% | 0.31% |
| Return on Equity (TTM) | 0.12% | 0.17% |
| Debt to Equity (MRQ) | 6.52 | 0.00 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹268.63 | ₹87.89 |
| Cash per Share (MRQ) | ₹119.26 | ₹54.65 |
| Operating Cash Flow (TTM) | ₹2.95B | ₹185.37M |
| Levered Free Cash Flow (TTM) | ₹3.39B | ₹181.55M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.33% | 0.17% |
| Last 12-Month Dividend | ₹6.50 | ₹1.00 |
Valuation & Enterprise Metrics Analysis: Poly Medicure vs Prevest Denpro
| Metric | POLYMED | PREVEST |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 53.26 | 34.49 |
| Forward P/E | 246.24 | N/A |
| PEG Ratio | 2.77 | 1.73 |
| Price to Sales (TTM) | 11.36 | 10.03 |
| Price to Book (MRQ) | 7.04 | 6.22 |
| Market Capitalization | ||
| Market Capitalization | ₹193.74B | ₹6.65B |
| Enterprise Value | ₹187.33B | ₹5.91B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 11.10 | 9.03 |
| Enterprise to EBITDA | 40.95 | 25.67 |
| Risk & Other Metrics | ||
| Beta | 0.01 | 0.43 |
| Book Value per Share (MRQ) | ₹268.63 | ₹87.89 |
Financial Statements Comparison: Poly Medicure vs Prevest Denpro
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | POLYMED | PREVEST |
|---|---|---|
| Revenue/Sales | ₹4.03B | ₹157.66M |
| Cost of Goods Sold | ₹1.27B | ₹35.59M |
| Gross Profit | ₹2.76B | ₹122.08M |
| Research & Development | ₹66.81M | N/A |
| Operating Income (EBIT) | ₹828.81M | ₹48.22M |
| EBITDA | ₹1.49B | ₹64.79M |
| Pre-Tax Income | ₹1.23B | ₹59.88M |
| Income Tax | ₹298.63M | ₹15.83M |
| Net Income (Profit) | ₹930.83M | ₹44.05M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | POLYMED | PREVEST |
|---|---|---|
| Cash & Equivalents | ₹86.99M | ₹608.98M |
| Total Current Assets | ₹19.17B | ₹857.15M |
| Total Current Liabilities | ₹3.70B | ₹59.62M |
| Long-Term Debt | ₹7.71M | ₹0 |
| Total Shareholders Equity | ₹27.66B | ₹1.06B |
| Retained Earnings | ₹10.14B | ₹733.61M |
| Property, Plant & Equipment | ₹24.01M | ₹13.99M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | POLYMED | PREVEST |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | POLYMED | PREVEST |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 146,443 | 2,840 |
| Average Daily Volume (90 Day) | 180,925 | 8,133 |
| Shares Outstanding | 101.33M | 12.00M |
| Float Shares | 33.23M | 2.48M |
| % Held by Insiders | 0.67% | 0.78% |
| % Held by Institutions | 0.20% | 0.00% |
Dividend Analysis & Yield Comparison: Poly Medicure vs Prevest Denpro
| Metric | POLYMED | PREVEST |
|---|---|---|
| Last 12-Month Dividend | ₹6.50 | ₹1.00 |
| Last 12-Month Dividend Yield | 0.33% | 0.17% |
| 3-Year Avg Annual Dividend | ₹3.17 | ₹0.33 |
| 3-Year Avg Dividend Yield | 0.18% | 0.17% |
| 3-Year Total Dividends | ₹9.50 | ₹1.00 |
| Ex-Dividend Date | Sep 18, 2025 | Sep 03, 2025 |